These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6149347)

  • 21. Control measures against hepatitis B infection.
    Frösner GG; Franco E
    Ann Ist Super Sanita; 1987; 24(2):267-75. PubMed ID: 2969204
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response to hepatitis B vaccine in medical & paramedical personnel in India.
    Sehgal A; Pavri K; Arankalle V; Jhala CI; Dhorje SP; Ramamoorthy CL
    Indian J Med Res; 1987 Mar; 85():231-4. PubMed ID: 2956189
    [No Abstract]   [Full Text] [Related]  

  • 23. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune response to hepatitis B vaccine and duration of protection in a dialysis unit].
    Magnani G; Calzetti C; Campari M; Lehndorff H; Pizzaferri P; Rossi E
    Acta Biomed Ateneo Parmense; 1987; 58(1-2):41-7. PubMed ID: 2960120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contamination by hepatitis C in a haemodialysis center: preventive measures.
    Guiserix J
    Nephron; 1996; 72(4):721-2. PubMed ID: 8730457
    [No Abstract]   [Full Text] [Related]  

  • 27. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination against hepatitis B in patients on chronic haemodialysis.
    Kovacic V
    Int J Clin Pract; 2003 Apr; 57(3):161-2. PubMed ID: 12723714
    [No Abstract]   [Full Text] [Related]  

  • 29. Trial of SKF rDNA hepatitis B vaccine.
    Milne A
    N Z Med J; 1989 Apr; 102(866):198-9. PubMed ID: 2523526
    [No Abstract]   [Full Text] [Related]  

  • 30. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
    Tarocco RP; Faro G; Sargiotto A; Visconti C
    Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous administration of hepatitis B and yellow fever vaccines.
    Yvonnet B; Coursaget P; Deubel V; Diop-Mar I; Digoutte JP; Chiron JP
    Dev Biol Stand; 1986; 65():205-7. PubMed ID: 2951287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses].
    Corbella E; Garghetti L; Poloniato A; Zambelloni C; Consonni A
    Minerva Pediatr; 1987 Oct; 39(20):821-6. PubMed ID: 2963953
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonresponse to hepatitis B vaccine.
    N Engl J Med; 1990 Feb; 322(8):550-2. PubMed ID: 2137197
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immune response to recombinant anti-hepatitis-B vaccine in a group at risk].
    León A; García Marcos JA; Nash R; Asensio A; Sanz T; Mateos Lindemann M
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):660-1. PubMed ID: 2151508
    [No Abstract]   [Full Text] [Related]  

  • 36. More about response to hepatitis B vaccine in hemodialysis patients.
    Vagelli G; Calabrese G; Mazzotta A; Pratesi G; Gonella M
    Nephron; 1988; 49(2):171. PubMed ID: 2967921
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis A and B vaccines in children.
    Lieberman JM; Greenberg DP
    Adv Pediatr Infect Dis; 1996; 11():333-63. PubMed ID: 8718466
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National surveillance of dialysis-associated diseases in the United States, 1989.
    Alter MJ; Favero MS; Moyer LA; Bland LA
    ASAIO Trans; 1991; 37(2):97-109. PubMed ID: 1830208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to hepatitis B vaccine among haemodialysis patients.
    Jaiswal SB; Chitnis DS
    Lancet; 1995 Nov; 346(8986):1363. PubMed ID: 7475791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.